see notes below-indicators good has 23 holdings focus on growth
see new note below-all indicators good
see notes below first-percent r upper-aroon crossed
almost out of weekly cloud-use limits-5 percent risk capital-trailing stop close below 8 ema
enter on positive short term candle to confirm-diversify longs and shorts-trailing stop loss close below 8 ema-chat room labor day get in early enter on limit to buy pullback-long term and medium up since early aug
enter only on positive candle for direction-diversify target bottom of weekly cloud-trailing stop loss 8 ema-buy our book on amazon-
The wave 2 correction in Mangalam Drugs seems to have become a bit complex. Now it appears to be at a structural support. Also there is 61% Fib support. So it's likely that the up move could start. Any move below wave 1 low would negate this setup.
good money flow use limit//stop top of cloud/macd crossed/cci and percent r in upper band/diversify with juniors/enter on good 21 minute bar re fib pullback/adx starting trend/next level 200 weekly.16
Consistent outperformer with always an Ace up its sleeve. Expect at least a 30% increase in value in 2016. You will never see this stock at these prices ever again. Buy now and thank me Later. All bets are off if we have a financial collapse dragging the share price below 92.96.
Harvard Apparatus Regentive Technology is a bioscience company working on more natural heart valve replacements and other pretty cool biotech stuff. However my interest is because the way they are ramping up for another go after moving from $0.60 to $3.25 in less than a month. This is shaping up to be your typical "head and shoulders" scenario. HART's 1day MACD...